The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells - PubMed (original) (raw)
. 1993 Oct 15;268(29):21592-8.
Affiliations
- PMID: 7691813
Free article
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells
G L Lukacs et al. J Biol Chem. 1993.
Free article
Abstract
Deletion of the phenylalanine at position 508 of the cystic fibrosis transmembrane conductance regulator (CFTR) is the most prevalent mutation in cystic fibrosis (CF). This mutation (delta F508CFTR) leads to a reduced cAMP-sensitive Cl- conductance in epithelial cells. While the mutant protein can function as a Cl- channel, it seems to be misprocessed and unable to accumulate at normal levels in the plasma membrane. Under conditions where the biosynthetic block of delta F508CFTR is not complete, the residence time of delta F508CFTR in the plasma membrane is a critical determinant of the cAMP-sensitive Cl- conductance. To assess the stability of the mutant and wild-type CFTR, we compared their functional half-lives at the plasma membrane of transfected Chinese hamster ovary cells. The plasma membrane Cl- conductance was assessed by patch-clamp recordings and/or by fluorimetric determinations of the membrane potential. Accumulation of delta F508CFTR in the plasma membrane was promoted by growing the transfected cells at reduced temperature (24-28 degrees C), and was verified by immunoblotting and by detecting the appearance of a plasmalemmal cAMP-activated Cl- conductance. Subsequently increasing the temperature to 37 degrees C inhibited further delivery of newly synthesized delta F508CFTR to the surface membrane. By studying the time dependence of the disappearance of the Cl- conductance, the functional half-life of the mutant protein at the plasma membrane was determined to be < 4 h, which is considerably shorter than the half-life of wild-type CFTR (> 24 h). The latter was estimated by terminating protein synthesis or secretion with cycloheximide or brefeldin A, respectively. Inhibition of protein synthesis did not alter the rate of disappearance of delta F508CFTR at 37 degrees C, validating the difference in turnover between mutant and wild-type CFTR. These results indicate that the structural abnormality of delta F508CFTR affects not only the delivery of the protein to the plasma membrane, but also its stability therein. Moreover, they suggest that overcoming the processing block at the endoplasmic reticulum may not suffice to restore normal Cl- conductance in CF.
Similar articles
- Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Denning GM, et al. Nature. 1992 Aug 27;358(6389):761-4. doi: 10.1038/358761a0. Nature. 1992. PMID: 1380673 - Expression of cystic fibrosis transmembrane conductance regulator alters the responses to hypotonic cell swelling and ATP of Chinese hamster ovary cells.
Thiele IE, Hug MJ, Hübner M, Greger R. Thiele IE, et al. Cell Physiol Biochem. 1998;8(1-2):61-74. doi: 10.1159/000016271. Cell Physiol Biochem. 1998. PMID: 9547020 - Dysfunction of CFTR bearing the delta F508 mutation.
Welsh MJ, Denning GM, Ostedgaard LS, Anderson MP. Welsh MJ, et al. J Cell Sci Suppl. 1993;17:235-9. J Cell Sci Suppl. 1993. PMID: 7511616 Review. - Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA. Stanton BA. Wien Klin Wochenschr. 1997 Jun 27;109(12-13):457-64. Wien Klin Wochenschr. 1997. PMID: 9261986 Review.
Cited by
- Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect.
Dong Q, Ostedgaard LS, Rogers C, Vermeer DW, Zhang Y, Welsh MJ. Dong Q, et al. Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):917-22. doi: 10.1073/pnas.1120065109. Epub 2011 Dec 30. Proc Natl Acad Sci U S A. 2012. PMID: 22210114 Free PMC article. - Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.
Gentzsch M, Chang XB, Cui L, Wu Y, Ozols VV, Choudhury A, Pagano RE, Riordan JR. Gentzsch M, et al. Mol Biol Cell. 2004 Jun;15(6):2684-96. doi: 10.1091/mbc.e04-03-0176. Epub 2004 Apr 9. Mol Biol Cell. 2004. PMID: 15075371 Free PMC article. - Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine.
Pranke I, Golec A, Hinzpeter A, Edelman A, Sermet-Gaudelus I. Pranke I, et al. Front Pharmacol. 2019 Feb 27;10:121. doi: 10.3389/fphar.2019.00121. eCollection 2019. Front Pharmacol. 2019. PMID: 30873022 Free PMC article. Review. - Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.
Liu J, Bihler H, Farinha CM, Awatade NT, Romão AM, Mercadante D, Cheng Y, Musisi I, Jantarajit W, Wang Y, Cai Z, Amaral MD, Mense M, Sheppard DN. Liu J, et al. Br J Pharmacol. 2018 Apr;175(7):1017-1038. doi: 10.1111/bph.14141. Epub 2018 Feb 22. Br J Pharmacol. 2018. PMID: 29318594 Free PMC article. - Recent progress in translational cystic fibrosis research using precision medicine strategies.
Cholon DM, Gentzsch M. Cholon DM, et al. J Cyst Fibros. 2018 Mar;17(2S):S52-S60. doi: 10.1016/j.jcf.2017.09.005. Epub 2017 Oct 4. J Cyst Fibros. 2018. PMID: 28986017 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources